Skip to search formSkip to main contentSkip to account menu

nephritogenoside

Known as: D-Glucose, O-alpha-D-glucopyranosyl-(1-6)-O-D-glucopyranosyl-(1-6)-, nephritogenic glycopeptide, nephritogenic glycoprotein 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
Vitamin D treatment was tried when renal osteodystrophy was first recognized in the early 20th century, using vitamin D2, D3, or… 
1992
1992
Nephritogenoside has been prepared by coupling of the acylazide derivative of N-triglycosyl dipeptide with nonadecapeptide… 
1990
1990
Normal rat renal cortex contains three renal disease-inducing substances, that is, nephritogenoside, FX1A and immunogenoside (a… 
1989
1989
Nephritogenoside is a minor component of the basement membrane of normal animals (including humans). It is a glycopeptide with… 
1986
1986
Nephritogenic glycopeptide, nephritogenoside, is a minor component of basement membranes (the yield: 2-3 micrograms/kidney), and… 
1983
1983
An enzyme linked immunosorbent assay (ELISA) was introduced for the detection of nephritogenic glycopeptide, nephritogenoside and… 
1981
1981
A new glycopeptide was isolated from the glomerular basement membrane (GBM) of normal rats. Unlike already known glycopeptides…